Skip to main content

ROYAL LONDON ASSET MANAGEMENT LTD

Position in ABBV — AbbVie Inc.

CIK 863748 UNITED KINGDOM, X0

Position in ABBV

as of Mar 31, 2026 · filed May 1, 2026
Position Value
$293,984,930
-$6,449,259 QoQ
Shares Held
1,351,717
+2.8% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.78050139193337.ToString("F0")% Shared 0.ToString("F0")% None 0.21949860806662935.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

ROYAL LONDON ASSET MANAGEMENT LTD holds $3,896,027,978 across 10 Drug Manufacturers - General names. ABBV ranks #5 (7.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 ABBV
AbbVie Inc.
This page
1,351,717 $293,984,930

All Filings in ABBV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $293,984,930 1,351,717
2025-12-31 $300,434,189 1,314,868
2025-09-30 $302,223,141 1,305,274
2025-06-30 $243,915,445 1,314,058
2025-03-31 $284,829,659 1,359,439
2024-12-31 $231,937,949 1,305,222
2024-09-30 $270,801,954 1,371,288
2024-06-30 $233,102,540 1,359,040
2024-03-31 $267,651,308 1,469,804
2023-12-31 $213,059,884 1,374,846
2023-09-30 $191,005,931 1,281,403
2023-06-30 $160,221,185 1,189,202
2023-03-31 $158,749,731 996,108
2022-12-31 $149,759,300 926,671
2022-09-30 $121,746,856 907,137
2022-06-30 $146,268,565 955,005
2022-03-31 $155,319,374 958,111
2021-12-31 $119,757,779 884,474
2021-09-30 $100,059,025 927,589
2021-06-30 $106,642,145 946,752
2021-03-31 $105,339,508 973,383
2020-12-31 $101,718,887 949,313
2020-09-30 $82,913,832 946,613
2020-06-30 $91,120,072 928,092
2020-03-31 $64,206,760 842,719